Market Research Logo

Biotechnology in the Netherlands

Introduction

Biotechnology in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Netherlands biotechnology market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

  • The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
  • The Dutch biotechnology industry had total revenues of $352.1m in 2014, representing a compound annual growth rate (CAGR) of 0.8% between 2010 and 2014.
  • The medical/healthcare segment was the industry's most lucrative in 2014, with total revenues of $265m, equivalent to 75.3% of the industry's overall value.
  • The performance of the industry is forecast to accelerate, with an anticipated CAGR of 4.7% for the five-year period 2014 - 2019, which is expected to drive the industry to a value of $441.9m by the end of 2019.
Features

Save time carrying out entry-level research by identifying the size, growth, and leading players in the biotechnology market in the Netherlands

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the Netherlands

Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Netherlands economy

Key Questions Answered

What was the size of the Netherlands biotechnology market by value in 2014?

What will be the size of the Netherlands biotechnology market in 2019?

What factors are affecting the strength of competition in the Netherlands biotechnology market?

How has the market performed over the last five years?


Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Actelion Ltd
AstraZeneca PLC
Biogen Idec, Inc.
Crucell N.V.
Macroeconomic Indicators
Country Data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
LIST OF TABLES
Table 1: Netherlands biotechnology industry value: $ million, 2010–14(e)
Table 2: Netherlands biotechnology industry category segmentation: $ million, 2014(e)
Table 3: Netherlands biotechnology industry geography segmentation: $ million, 2014(e)
Table 4: Netherlands biotechnology industry value forecast: $ million, 2014–19
Table 5: Actelion Ltd: key facts
Table 6: Actelion Ltd: key financials ($)
Table 7: Actelion Ltd: key financials (CHF)
Table 8: Actelion Ltd: key financial ratios
Table 9: AstraZeneca PLC: key facts
Table 10: AstraZeneca PLC: key financials ($)
Table 11: AstraZeneca PLC: key financial ratios
Table 12: Biogen Idec, Inc.: key facts
Table 13: Biogen Idec, Inc.: key financials ($)
Table 14: Biogen Idec, Inc.: key financial ratios
Table 15: Crucell N.V.: key facts
Table 16: Netherlands size of population (million), 2010–14
Table 17: Netherlands gdp (constant 2005 prices, $ billion), 2010–14
Table 18: Netherlands gdp (current prices, $ billion), 2010–14
Table 19: Netherlands inflation, 2010–14
Table 20: Netherlands consumer price index (absolute), 2010–14
Table 21: Netherlands exchange rate, 2010–14
LIST OF FIGURES
Figure 1: Netherlands biotechnology industry value: $ million, 2010–14(e)
Figure 2: Netherlands biotechnology industry category segmentation: % share, by value, 2014(e)
Figure 3: Netherlands biotechnology industry geography segmentation: % share, by value, 2014(e)
Figure 4: Netherlands biotechnology industry value forecast: $ million, 2014–19
Figure 5: Forces driving competition in the biotechnology industry in the Netherlands, 2014
Figure 6: Drivers of buyer power in the biotechnology industry in the Netherlands, 2014
Figure 7: Drivers of supplier power in the biotechnology industry in the Netherlands, 2014
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the Netherlands, 2014
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the Netherlands, 2014
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the Netherlands, 2014
Figure 11: Actelion Ltd: revenues & profitability
Figure 12: Actelion Ltd: assets & liabilities
Figure 13: AstraZeneca PLC: revenues & profitability
Figure 14: AstraZeneca PLC: assets & liabilities
Figure 15: Biogen Idec, Inc.: revenues & profitability
Figure 16: Biogen Idec, Inc.: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report